HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis

Standard

HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis. / Schneegans, Svenja; Löptien, Jana; Mojzisch, Angelika; Loreth, Desirée; Kretz, Oliver; Raschdorf, Christoph; Hanssen, Annkathrin; Gocke, Antonia; Siebels, Bente; Gunasekaran, Karthikeyan; Ding, Yi; Oliveira-Ferrer, Leticia; Brylka, Laura; Schinke, Thorsten; Schlüter, Hartmut; Paatero, Ilkka; Voß, Hannah; Werner, Stefan; Pantel, Klaus; Wikman, Harriet.

in: J EXP CLIN CANC RES, Jahrgang 43, Nr. 1, 11.04.2024, S. 110.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{d5aca858cb1445afb1d5811163713b45,
title = "HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis",
abstract = "BACKGROUND: Metastasis is the leading cause of cancer-related death in non-small cell lung cancer (NSCLC) patients. We previously showed that low HERC5 expression predicts early tumor dissemination and a dismal prognosis in NSCLC patients. Here, we performed functional studies to unravel the mechanism underlying the {"}metastasis-suppressor{"} effect of HERC5, with a focus on mitochondrial metabolism pathways.METHODS: We assessed cell proliferation, colony formation potential, anchorage-independent growth, migration, and wound healing in NSCLC cell line models with HERC5 overexpression (OE) or knockout (KO). To study early tumor cell dissemination, we used these cell line models in zebrafish experiments and performed intracardial injections in nude mice. Mass spectrometry (MS) was used to analyze protein changes in whole-cell extracts. Furthermore, electron microscopy (EM) imaging, cellular respiration, glycolytic activity, and lactate production were used to investigate the relationships with mitochondrial energy metabolism pathways.RESULTS: Using different in vitro NSCLC cell line models, we showed that NSCLC cells with low HERC5 expression had increased malignant and invasive properties. Furthermore, two different in vivo models in zebrafish and a xenograft mouse model showed increased dissemination and metastasis formation (in particular in the brain). Functional enrichment clustering of MS data revealed an increase in mitochondrial proteins in vitro when HERC5 levels were high. Loss of HERC5 leads to an increased Warburg effect, leading to improved adaptation and survival under prolonged inhibition of oxidative phosphorylation.CONCLUSIONS: Taken together, these results indicate that low HERC5 expression increases the metastatic potential of NSCLC in vitro and in vivo. Furthermore, HERC5-induced proteomic changes influence mitochondrial pathways, ultimately leading to alterations in energy metabolism and demonstrating its role as a new potential metastasis suppressor gene.",
author = "Svenja Schneegans and Jana L{\"o}ptien and Angelika Mojzisch and Desir{\'e}e Loreth and Oliver Kretz and Christoph Raschdorf and Annkathrin Hanssen and Antonia Gocke and Bente Siebels and Karthikeyan Gunasekaran and Yi Ding and Leticia Oliveira-Ferrer and Laura Brylka and Thorsten Schinke and Hartmut Schl{\"u}ter and Ilkka Paatero and Hannah Vo{\ss} and Stefan Werner and Klaus Pantel and Harriet Wikman",
note = "{\textcopyright} 2024. The Author(s).",
year = "2024",
month = apr,
day = "11",
doi = "10.1186/s13046-024-03020-z",
language = "English",
volume = "43",
pages = "110",
journal = "J EXP CLIN CANC RES",
issn = "1756-9966",
publisher = "BioMed Central Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis

AU - Schneegans, Svenja

AU - Löptien, Jana

AU - Mojzisch, Angelika

AU - Loreth, Desirée

AU - Kretz, Oliver

AU - Raschdorf, Christoph

AU - Hanssen, Annkathrin

AU - Gocke, Antonia

AU - Siebels, Bente

AU - Gunasekaran, Karthikeyan

AU - Ding, Yi

AU - Oliveira-Ferrer, Leticia

AU - Brylka, Laura

AU - Schinke, Thorsten

AU - Schlüter, Hartmut

AU - Paatero, Ilkka

AU - Voß, Hannah

AU - Werner, Stefan

AU - Pantel, Klaus

AU - Wikman, Harriet

N1 - © 2024. The Author(s).

PY - 2024/4/11

Y1 - 2024/4/11

N2 - BACKGROUND: Metastasis is the leading cause of cancer-related death in non-small cell lung cancer (NSCLC) patients. We previously showed that low HERC5 expression predicts early tumor dissemination and a dismal prognosis in NSCLC patients. Here, we performed functional studies to unravel the mechanism underlying the "metastasis-suppressor" effect of HERC5, with a focus on mitochondrial metabolism pathways.METHODS: We assessed cell proliferation, colony formation potential, anchorage-independent growth, migration, and wound healing in NSCLC cell line models with HERC5 overexpression (OE) or knockout (KO). To study early tumor cell dissemination, we used these cell line models in zebrafish experiments and performed intracardial injections in nude mice. Mass spectrometry (MS) was used to analyze protein changes in whole-cell extracts. Furthermore, electron microscopy (EM) imaging, cellular respiration, glycolytic activity, and lactate production were used to investigate the relationships with mitochondrial energy metabolism pathways.RESULTS: Using different in vitro NSCLC cell line models, we showed that NSCLC cells with low HERC5 expression had increased malignant and invasive properties. Furthermore, two different in vivo models in zebrafish and a xenograft mouse model showed increased dissemination and metastasis formation (in particular in the brain). Functional enrichment clustering of MS data revealed an increase in mitochondrial proteins in vitro when HERC5 levels were high. Loss of HERC5 leads to an increased Warburg effect, leading to improved adaptation and survival under prolonged inhibition of oxidative phosphorylation.CONCLUSIONS: Taken together, these results indicate that low HERC5 expression increases the metastatic potential of NSCLC in vitro and in vivo. Furthermore, HERC5-induced proteomic changes influence mitochondrial pathways, ultimately leading to alterations in energy metabolism and demonstrating its role as a new potential metastasis suppressor gene.

AB - BACKGROUND: Metastasis is the leading cause of cancer-related death in non-small cell lung cancer (NSCLC) patients. We previously showed that low HERC5 expression predicts early tumor dissemination and a dismal prognosis in NSCLC patients. Here, we performed functional studies to unravel the mechanism underlying the "metastasis-suppressor" effect of HERC5, with a focus on mitochondrial metabolism pathways.METHODS: We assessed cell proliferation, colony formation potential, anchorage-independent growth, migration, and wound healing in NSCLC cell line models with HERC5 overexpression (OE) or knockout (KO). To study early tumor cell dissemination, we used these cell line models in zebrafish experiments and performed intracardial injections in nude mice. Mass spectrometry (MS) was used to analyze protein changes in whole-cell extracts. Furthermore, electron microscopy (EM) imaging, cellular respiration, glycolytic activity, and lactate production were used to investigate the relationships with mitochondrial energy metabolism pathways.RESULTS: Using different in vitro NSCLC cell line models, we showed that NSCLC cells with low HERC5 expression had increased malignant and invasive properties. Furthermore, two different in vivo models in zebrafish and a xenograft mouse model showed increased dissemination and metastasis formation (in particular in the brain). Functional enrichment clustering of MS data revealed an increase in mitochondrial proteins in vitro when HERC5 levels were high. Loss of HERC5 leads to an increased Warburg effect, leading to improved adaptation and survival under prolonged inhibition of oxidative phosphorylation.CONCLUSIONS: Taken together, these results indicate that low HERC5 expression increases the metastatic potential of NSCLC in vitro and in vivo. Furthermore, HERC5-induced proteomic changes influence mitochondrial pathways, ultimately leading to alterations in energy metabolism and demonstrating its role as a new potential metastasis suppressor gene.

U2 - 10.1186/s13046-024-03020-z

DO - 10.1186/s13046-024-03020-z

M3 - SCORING: Journal article

C2 - 38605423

VL - 43

SP - 110

JO - J EXP CLIN CANC RES

JF - J EXP CLIN CANC RES

SN - 1756-9966

IS - 1

ER -